View Older Stories View More Recent Stories
-
UPDATE: RBC Capital Starts Constellation Energy (CEG) at Outperform
-
UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT MAY HEALTHCARE CONFERENCES
-
Orchid Island Capital Announces First Quarter 2022 Results
-
T-Mobile US, (TMUS) Remains a Safe Place to Hide - RBC Capital
-
Tech Giants Commit Nearly $1 Billion Toward Carbon Capture
-
Crown Holdings (CCK) PT Raised to $143 at RBC Capital
-
Chubb Corporation (CB) PT Raised to $243 at RBC Capital Following Earnings
-
impact.com Announces Secondary Investment from W Capital and Providence Public of Approximately $100 Million
-
Sorenson Ventures Expands Investment Team
-
UPDATE: RBC Capital Downgrades Potlatch (PCH) to Sector Perform
-
Europe decries 'blackmail' as Russia cuts gas to Poland, Bulgaria
-
Anglo Pacific Group PLC Announces Q1 2022 Trading Update
-
RBC Capital Starts Jacobs Engineering Group Inc. (J) at Outperform
-
Modivcare Names Kevin Ellich as Vice President, Head of Investor Relations
-
Amwell to Participate in Upcoming Investor Conferences
-
UPDATE: Coca-Cola (KO) PT Raised to $69 at RBC Capital on Strong Organic Sales
-
Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences
-
BELLUS Health to Participate in Multiple Upcoming Investor Conferences
-
Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Satellogic Inc (SATL) Partners with Orbital Insight
-
Orbital Insight Announces Partnership with Satellogic to Bring Planetary Scale Insights to Customers Globally
-
UPDATE: AT&T (T) PT Lowered to $20 at RBC Capital After Updating the Model for Earnings and Warner
-
Global miners must overcome labour shortages, inflation pain to meet targets
-
GREEN IMPACT PARTNERS REPORTS FISCAL 2021 RESULTS; GIP TO EXPLORE STRATEGIC INVESTMENTS FOR ITS NEAR-TERM RNG PORTFOLIO
-
China slowdown concerns dim Ray-ban maker EssilorLuxottica's first quarter
-
RBC Capital Defending Sarepta Therapeutics (SRPT), 'we see value in SRPT's gene therapy programs that is not captured at current levels and remain buyers', PT $150
-
UPDATE: RBC Capital Upgrades ExxonMobil (XOM) to Outperform
-
UPDATE: RBC Capital Downgrades Chevron (CVX) to Sector Perform
-
MRF 2022 Resource Limited Partnership Closes IPO
-
Heat Biologics (“NightHawk Biosciences”) Completes Acquisition of Elusys Therapeutics
-
Heat Biologics (“NightHawk Biosciences”) Completes Acquisition of Elusys Therapeutics
-
Travelers (TRV) PT Lowered to $183 at RBC Capital
-
Halliburton (HAL) PT Raised to $49 at RBC Capital
-
UPDATE: RBC Capital Upgrades Palantir Technologies Inc. (PLTR) to Sector Perform
-
RBC Capital Downgrades Kinross Gold (KGC) to Sector Perform
-
RBC Capital Downgrades IAMGOLD (IAG) to Underperform
-
The Jordan Company Announces Strategic Investment in Communications & Power Industries
-
MeiraGTx to Participate in Upcoming Investor and Scientific Conferences
-
MeiraGTx to Participate in Upcoming Investor and Scientific Conferences
-
LiquidX Names Dominic Capolongo as Chief Revenue Officer
-
LiquidX Names Dominic Capolongo as Chief Revenue Officer
-
Rio Tinto Plc. (RIO:LN) (RIO) PT Raised to GBP56 at RBC Capital
-
Chemtrade Launches Process to Sell Vancouver Real Estate Through a Sale-Leaseback Transaction
-
Bank of New York Mellon (BK) PT Lowered to $56 at RBC Capital
-
Vale S.A. (VALE) PT Raised to $20 at RBC Capital
-
RBC Capital Starts Guidewire (GWRE) at Outperform
-
Ara Partners Promotes Katy Boettcher to Principal and Adds Ken Nguyen as Senior Associate
-
Anglo Pacific Group PLC Announces Favourable Four Mile Legal Dispute Ruling
-
ELS Reports First Quarter Results
-
MHS and Fortna to Combine to Create Global eCommerce and Logistics Automation Leader

